Filing Details
- Accession Number:
- 0001372514-24-000115
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-12 06:32:55
- Reporting Period:
- 2024-09-11
- Accepted Time:
- 2024-09-12 06:32:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1372514 | Kiora Pharmaceuticals Inc | KPRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1861519 | N. Carmine Stengone | C/O Kiora Pharmaceuticals, Inc. 332 Encinitas Blvd., Suite 102 Encinitas CA 92024 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-09-11 | 1,250 | $3.68 | 1,250 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The shares were purchased in multiple transactions at prices ranging from $3.65 to $3.73. The reported price of $3.68 represents the volume weighted average price for the reported transaction. The reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
